Cargando…

Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study

OBJECTIVE: To determine whether reducing the cetrorelix dose in the antagonist protocol to 0.125 mg had any deleterious effects on follicular development, the number and quality of retrieved oocytes, or the number of embryos, and to characterize its effects on the affordability of assisted reproduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Ayman S., Algergawy, Adel, Elhalwagy, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Reproductive Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783921/
https://www.ncbi.nlm.nih.gov/pubmed/29376021
http://dx.doi.org/10.5653/cerm.2017.44.4.232